organogenesis.com (ORGO): Narxning prognoz qilingan daromadga nisbati

ORGO (Organogenesis) - kompaniyaning tovar belgisi

Organogenesis Holdings daromad dinamikasi hozirda, forward P/S koeffitsienti bilan tasdiqlanganidek, yangilangan davlat to'lovlariga moslashmoqda. 0.30 darajasi ushbu ko'rsatkichning joriy qiymatini aks ettiradi. O'sish jarayoni jarrohlar uchun to'qimalarni bioinjenering sohasidagi yetakchilik bilan ta'minlanmoqda. Murakkab jarohatlarni davolash bo'yicha noyob patentlar premium narxlarni belgilash imkonini berib, tibbiyot sohasida mahalliy monopoliyani yaratmoqda.

ORGO organogenesis.com: Bozor kapitallashuvining kelajakdagi daromadga nisbati 04.07.2022 - 16.11.2026 oraligʻida

ORGO (organogenesis.com): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- joriy narx va aksiyalarning prognoz qilingan qiymati:
- birja kapitallashuvi ma'lumotlari:
Kompaniyaning fundamental baholanishi:organogenesis.com ORGO
Organogenesis Holdings tovar namunasi

Organogenesis Holdings (ORGO) regenerativ tibbiyot segmentidagi raqobatchilar uchun kirishning yuqori to'sig'ini yaratishda noyob patentlar va sug'urta kodlaridan foydalanadi. Taxminiy forward P/S koeffitsiyenti kompaniyaning joriy bozor qiymatini uning prognoz qilingan yillik daromadi bilan solishtirish orqali ushbu ustunlikni miqdoriy baholaydi. Ushbu metrika kelajakdagi daromadlar qiymatini baholash imkonini beradi, standart hisobotlar bilan bog'liq vaqt kechikishlarini bartaraf etadi va pul oqimi bo'shlig'i risklarini hisobga oladi. Taxminiy forward P/S tendentsiyasini tahlil qilish investorlarga aktiv haddan tashqari sotib olinganini yoki qarz yuklamasining kritik darajada oshganini o'z vaqtida aniqlashga yordam beradi.

Raqobatchilar tahlili

Forvard P/S multiplikatori HCA (HCA Healthcare, Inc.)|Narxning kutilayotgan daromadga nisbati THC (Tenet Healthcare)|FMS - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati solventum.com|EHC: Forvard P/S multiplikatori|UHS - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|DVA (DaVita Corp) - Forvard P/S multiplikatori|RDNT: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori OPCH|SGRY (surgerypartners.com) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori PINC (Premier Inc)|National Vision - Narxning prognoz qilingan daromadga nisbati|PGNY - Narxning prognoz qilingan daromadga nisbati|ARDT - Forvard P/S multiplikatori|SEM: Forvard P/S multiplikatori|astranahealth.com (ASTH) - Forvard P/S multiplikatori|MD (mednax.com) - Forvard P/S multiplikatori|Forvard P/S multiplikatori usph.com|Forvard P/S multiplikatori PNTG|NUTX (Nutex Health Corp) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori AUNA (Auna S.A.)|SBC Medical Group Holdings Inc (SBC) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|EOLS - Narxning prognoz qilingan daromadga nisbati|Sotuvga nisbatan forvard narx CYH (Community Health Systems Inc)|SKIN (beautyhealth.com) - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati MDWD|Narxning prognoz qilingan daromadga nisbati biote Corp.|Bozor kapitallashuvining kelajakdagi daromadga nisbati thejoint.com JYNT|Forvard P/S multiplikatori DCGO|Forvard narx/daromad multiplikatori P3 Health PIII|Forvard P/S multiplikatori GANX (Gain Therapeutics Inc.)|Forvard P/S multiplikatori EUDA Health Holdings Limited EUDA|baselmedical.com - Forvard P/S multiplikatori|CLGN: Narxning prognoz qilingan daromadga nisbati|Cuprina Holdings (Cayman) Ltd. (CUPR) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Concord Medical|AMS (American Shared Hospital Services Inc) - Forvard P/S multiplikatori|MEDIROM Corp (MRM) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori ALBT|Kapitalizatsiyaning kutilayotgan sotuvga nisbati DIH Holding|Forvard P/S multiplikatori XAGE (carmellcosmetics.com)|NIVF: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|ATIP: Forvard narx/daromad multiplikatori|CareMax Medical Group - Narxning kutilayotgan daromadga nisbati|Kindly MD (KDLY) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati MODV|Narxning prognoz qilingan daromadga nisbati Novo Integrated Sciences Corp|Bozor kapitallashuvining kelajakdagi daromadga nisbati SunLink Health Systems SSY|Narxning prognoz qilingan daromadga nisbati IMAC Corp (BACK)